… Erlotinib is a low molecular weight, orally active, epidermal growth … the comparative
effectiveness of pemetrexed and erlotinib. … In this study, only one trial conducted by Cappuzzo et al.…

… rates compared with erlotinib (P<0.05). Erlotinib resulted in a significantly longer MST
compared with gefitinib and icotinib (P<0.05). In conclusion, gefitinib, erlotinib and icotinib had …

… with erlotinib compared with gefitinib. If confirmed, our results indicate that erlotinib may
play an important role in controlling CNS progression from EGFR mutation-positive NSCLC. …

… In summary, this study demonstrated that both gefitinib and erlotinib showed effective anti-tumor …
Further study with inclusion of both gefitinib and erlotinib in a properly conducted and …

… Almost all of the included studies did not show any differences in all anti-… study reported an
unfavorable result for erlotinib, with both lower PFS and OS, which might relate to the erlotinib …

… suggest that the in vivo tumor uptake of [ 11 C]erlotinib and [ 18 … might be that in the current
study, [ 11 C]erlotinib and [ 18 F]… of [ 11 C]erlotinib and [ 18 F]afatinib in PET studies under …

… studies showed no differences in all indices of antitumor effectiveness, which was the basis
of our results. Only one study reported an unfavorable result against erlotinib, … in the erlotinib …

… Nine studies comprising 1698 patients with NSCLC were included in this meta-analysis, of
whom 850 were treated with erlotinib plus bevacizumab, and 848 with erlotinib. The erlotinib …

… Comparative studies have reported the efficacy of two types of EGFR-TKIs5-8, but there are
not a great number of studies that have compared between gefitinib and erlotinib in patients …

… followed by erlotinib has promising activity in previously treated patients [19], [20], [21], [22]. …
this study was to assess the efficacy and tolerability of second-line sequential erlotinib plus …